Similar articles

• Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.

  Walker AS, Ford D, Gilks CF, Munderi P, Ssali F, Reid A, Katabira E, Grosskurth H, Mugyenyi P, Hakim J, Darbyshire JH, Gibb DM, Babiker AG. Walker AS, et al. Lancet. 2010 Apr 10;375(9722):1278-86. doi: 10.1016/S0140-6736(10)60057-8. Epub 2010 Mar 27. Lancet. 2010. PMID: 20347483 Free PMC article.
• Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.

  Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, Ransom R, Kaharuza F, Culver D, Kizito F, Bunnell R, Kigozi A, Nakanjako D, Wafula W, Quick R. Mermin J, et al. Lancet. 2004 Oct 16-22;364(9443):1428-34. doi: 10.1016/S0140-6736(04)17225-5. Lancet. 2004. PMID: 15488218 Clinical Trial.
• Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa.

  Hoffmann CJ, Fielding KL, Charalambous S, Innes C, Chaisson RE, Grant AD, Churchyard GJ. Hoffmann CJ, et al. AIDS. 2010 Jul 17;24(11):1709-16. doi: 10.1097/QAD.0b013e32833ac6bc. AIDS. 2010. PMID: 20495439 Free PMC article. Clinical Trial.
• Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing?

  Miller RF. Miller RF. Thorax. 2000 Aug;55 Suppl 1(Suppl 1):S15-22. doi: 10.1136/thorax.55.suppl_1.s15. Thorax. 2000. PMID: 10943633 Free PMC article. Review. No abstract available.
• The expanding role of co-trimoxazole in developing countries.

  Church JA, Fitzgerald F, Walker AS, Gibb DM, Prendergast AJ. Church JA, et al. Lancet Infect Dis. 2015 Mar;15(3):327-39. doi: 10.1016/S1473-3099(14)71011-4. Epub 2015 Jan 21. Lancet Infect Dis. 2015. PMID: 25618179 Review.